Research payments
$101,241,667
Through program year 2025, $101,241,667 in research payments was reported against , across 8,822 payments, paid by GlaxoSmithKline, LLC..
- Paid by
- GlaxoSmithKline, LLC.
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $8,453,775 | 30 |
| 2024 | Research | $4,539,473 | 26 |
| 2023 | Research | $26,291,152 | 378 |
| 2022 | Research | $4,191,494 | 78 |
| 2021 | Research | $40,001,745 | 8,017 |
| 2020 | Research | $5,353,294 | 166 |
| 2019 | Research | $12,410,735 | 127 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Matthew Davis Rochester, NY Named on 378 payments
- Charles Andrews San Antonio, TX Named on 195 payments
- Cynthia Robbins Fort Worth, TX Named on 166 payments
- Peter Silas Layton, UT Named on 164 payments
- Hany Ahmed Houston, TX Named on 161 payments
- Stephen Stamatis Weatherford, TX Named on 158 payments
- Merlin Fausett Salt Lake City, UT Named on 158 payments
- Guy Middleton Dothan, AL Named on 153 payments
- John Paul Roberts Plano, TX Named on 139 payments
- Minesh Patel Lake City, FL Named on 134 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.